Myeloid-conditioning using Toll-like receptor agonists to restore immune potency against melanoma.

被引：0
|
作者：
Foureau, David [1 ,2 ]
Carpenter, Kendall [1 ]
Amin, Asim [3 ]
Guo, Fei [2 ]
White, Richard [4 ]
Salo, Jonathan [4 ]
机构：
[1] Carolinas Healthcare Syst, Gen Surg Res, Charlotte, NC USA
[2] Carolinas Healthcare Syst, Immune Monitoring Core Lab, Charlotte, NC USA
[3] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA
[4] Carolinas Healthcare Syst, Surg Oncol, Charlotte, NC USA
来源：
JOURNAL OF IMMUNOLOGY | 2014年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
TUM4P.926
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Toll-like receptor 3 agonists as direct cytotoxic agents against human melanoma cells
    Salaun, Bruno
    Rimoldi, Donata
    Romero, Pedro
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 881 - 882
  • [2] Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice
    Gao, Wenyan
    Sun, Xiaodan
    Li, Danni
    Sun, Lin
    He, Yang
    Wei, Huanping
    Jin, Feng
    Cao, Yaming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [3] Toll-like receptor 3 agonists as direct cytotoxic agents against human melanoma tumor cells
    Salaun, B.
    Rimoldi, D.
    Romero, P.
    SWISS MEDICAL WEEKLY, 2007, 137 : 30S - 30S
  • [4] Programming immune responses with polymer carriers of Toll-like receptor (TLR) agonists
    Lynn, Geoffrey
    Laga, Richard
    Seder, Bob
    Seymour, Len
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [5] Toll-like receptor agonists induce immunogeneicity and apoptosis of acute myeloid leukemia cells
    Shindo, Maki
    Liang, Xueqing
    Wang, Zhimei
    Miller, Jeffery S.
    Carroll, Martin
    Chen, Wei
    BLOOD, 2007, 110 (11) : 54A - 55A
  • [6] Tuning innate immune function using microneedles containing multiple classes of toll-like receptor agonists
    Edwards, Camilla
    Oakes, Robert S.
    Jewell, Christopher M.
    NANOSCALE, 2023, 15 (19) : 8662 - 8674
  • [7] The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus
    Salem, Mohamed L.
    El-Demellawy, Maha
    Abou El-Azm, Abdel Raouf
    CELLULAR IMMUNOLOGY, 2010, 262 (02) : 96 - 104
  • [8] Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists
    Bourquin, Carole
    Pommier, Aurelien
    Hotz, Christian
    PHARMACOLOGICAL RESEARCH, 2020, 154
  • [9] Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
    Rolfo, Christian
    Giovannetti, Elisa
    Martinez, Pablo
    McCue, Shannon
    Naing, Aung
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [10] Toll-Like Receptor 4 as an Immune Receptor Against Mycobacterium tuberculosis: A Systematic Review
    Sepehri, Zahra
    Kiani, Zohre
    Kohan, Farhad
    Ghavami, Saeid
    LABORATORY MEDICINE, 2019, 50 (02) : 117 - 129
12345